Abstract
The effects of clinical grade crude preparations of human chorionic gonadotropin (hCG) on Kaposi's sarcoma, HIV, SIV and hematopoiesis were examined in vitro and in vivo. In contrast to previous studies, we report that the antiviral activity of hCG associated factors is not due to the native hCC heterodimer, including its purified subunits or its major degradation product, the β-core. Using gel permeation chromatography of the clinical grade hCC and urine concentrates from pregnant women, we demonstrate that an as yet unidentified hCG associated factor (HAF) with anti-HIV, anti-SIV, anti-KS and pro-hematopoietic activities elutes as two peaks corresponding to 15–30 kDa and 2–4 kDa.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lunardi-Iskandar, Y. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64–68 (1995).
Lunardi-Iskandar, Y. et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J. Natl. Cancer Inst. 87, 974–981 (1995).
Hermans, P. & Clumeck, N. Kaposi's sarcoma in patients infected with human immunodeficiency virus (HIV): an overview. Cell. Mol. Biol. 3, 357–364 (1995).
Gill, P.S. et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N. Engl. J. Med. 335, 1261–1269 (1996).
Harris, P.J. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. The Lancet 346, 118–119 (1995).
Gill, P. et al. Phase I study of a preparation of human chorionic gonadotropin given subcutaneously to patients with AIDS-related Kaposi's sarcoma. J. Natl. Cancer Inst. 89, 1797–1802 (1997).
Hermans, P. et al. AIDS related Kaposi's sarcoma patients with visceral manifestations: response to human chorionic gonadotropin preparations. J. Human Virol. 1, 82–89 (1998).
Letvin, N.L. & King, N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3, 1023–1040 (1990).
Kestler, H. et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109–1112 (1990).
Dickie, P. et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185, 109–119 (1991).
Franks, R.R. et al. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatr. Res. 37, 56–63 (1995).
Kopp, J.B. et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res. Hum. Retroviruses 9, 267–275 (1993).
Morse, J.H., Lustbader, J.W., Harrington, J.W. & Canfield, R.C. Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting. Am. J. Reprod. Immunol. Microbiol. 17, 134–140 (1988).
Birken, S. et al. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology 123, 572–583 (1988).
Morse, J.H., Stearns, G., Arden, J., Agosto, G.M. & Canfield, R.E. The effects of crude and purified human gonadotrpin on in vitro stimulated human lymphocyte cultures. Cell. Immunol. 25, 178–188 (1976).
Shijirslev, S.V. and Kevorkov, N.N. Relationship between the immunomodulating effects of chorionic gonadotropin and the intense functional activity of the splenocytes mediating the adoptive immune response. Probl. Endokrinal. [Mosk] 39, 54–57 (1993).
Albini, A. et al. The beta-core fragment of human chorionic gonadotropin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11, 713–721 (1997).
Bourinbaiar, A.S. & Lee-Huang, S. Anti-HIV effect of beta subunit of human chorionic gonadotropin (βhCG) in vitro. Immunol. Lett. 44, 13–18 (1995).
Swapan, D.E. et al. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice. J. Clin. Invest. 99, 1484–1491 (1997).
Griffiths, S.J. Ribonuclease inhibits Kaposi's sarcoma. Nature 390, 568 (1997).
Klotman, M.E. et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88, 5011–5015 (1991).
Popovic, M. et al. Detection, isolation, and continuous production of cyto-pathic retroviruses (HTLV-III) form patients with AIDS and pre-AIDS. Science 224, 497–500 (1984).
Gallo, R.C. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500–503 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lunardi-Iskandar, Y., Bryant, J., Blattner, W. et al. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 4, 428–434 (1998). https://doi.org/10.1038/nm0498-428
Issue Date:
DOI: https://doi.org/10.1038/nm0498-428
This article is cited by
-
Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice
Diabetologia (2007)
-
Mother knows best
Nature Medicine (1998)